An amino-terminal domain of the Sendai virus nucleocapsid protein is required for template function in viral RNA synthesis.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 191139)

Published in J Virol on February 01, 1997

Authors

T M Myers1, S A Moyer

Author Affiliations

1: Department of Molecular Genetics and Microbiology, University of Florida, College of Medicine, Gainesville 32610, USA.

Articles cited by this

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58

A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res (1988) 26.70

High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science (1989) 8.73

The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol (1993) 6.38

Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell (1992) 5.72

Systematic mutational analysis of the yeast ACT1 gene. Genetics (1992) 5.02

Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62

Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology (1992) 2.89

The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J (1991) 2.83

Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol (1992) 2.73

A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci U S A (1991) 2.43

High resolution analysis of functional determinants on human tissue-type plasminogen activator. J Biol Chem (1991) 2.02

An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. J Virol (1995) 1.98

Isolation and characterization of Sendai virus DI-RNAs. Cell (1976) 1.92

Clustered charged-to-alanine mutagenesis of poliovirus RNA-dependent RNA polymerase yields multiple temperature-sensitive mutants defective in RNA synthesis. J Virol (1994) 1.79

Conformation of the helical nucleocapsids of paramyxoviruses and vesicular stomatitis virus: reversible coiling and uncoiling induced by changes in salt concentration. Proc Natl Acad Sci U S A (1980) 1.76

Cloning and expression of a viral phosphoprotein: structure suggests vesicular stomatitis virus NS may function by mimicking an RNA template. J Gen Virol (1986) 1.66

The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation. J Virol (1993) 1.61

The conserved N-terminal region of Sendai virus nucleocapsid protein NP is required for nucleocapsid assembly. J Virol (1993) 1.55

In vitro replication of Sendai virus wild-type and defective interfering particle genome RNAs. J Virol (1985) 1.53

Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: mapping of domains on NP protein required for binding to P protein. J Virol (1991) 1.35

Mutations in conserved domain I of the Sendai virus L polymerase protein uncouple transcription and replication. Virology (1995) 1.33

Targeted construction of temperature-sensitive mutations in vaccinia virus by replacing clustered charged residues with alanine. Proc Natl Acad Sci U S A (1994) 1.27

Antibodies against Sendai virus L protein: distribution of the protein in nucleocapsids revealed by immunoelectron microscopy. Virology (1988) 1.24

The carboxy-terminal domain of Sendai virus nucleocapsid protein is involved in complex formation between phosphoprotein and nucleocapsid-like particles. Virology (1994) 1.17

Complete sequence of the Sendai virus NP gene from a cloned insert. Virology (1984) 1.15

Alternative amino acids at a single site in the Sendai virus L protein produce multiple defects in RNA synthesis in vitro. Virology (1995) 1.13

Localization of P, NP, and M proteins on Sendai virus nucleocapsid using immunogold labeling. Virology (1986) 1.11

Antibodies to paramyxovirus nucleoproteins define regions important for immunogenicity and nucleocapsid assembly. Virology (1993) 1.07

The molecular basis for growth hormone-receptor interactions. Recent Prog Horm Res (1993) 0.91

Measles virus nucleocapsid protein can function in Sendai virus defective interfering particle genome synthesis in vitro. Virology (1995) 0.87

Molecular evolution of human paramyxoviruses. Nucleotide sequence analyses of the human parainfluenza type 1 virus NP and M protein genes and construction of phylogenetic trees for all the human paramyxoviruses. Arch Virol (1992) 0.78

Articles by these authors

Translation and identification of the mRNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1975) 4.17

Messenger RNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1975) 3.04

Studies on the in vitro adenylation of RNA by vesicular stomatitis virus. Virology (1974) 2.83

Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol (1992) 2.73

Translation and identification of the viral mRNA species isolated from subcellular fractions of vesicular stomatitis virus-infected cells. J Virol (1975) 2.68

Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs. Proc Natl Acad Sci U S A (1986) 2.45

In vitro synthesis of methylated messenger RNA by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1974) 2.42

Methylated and blocked 5' termini in vesicular stomatitis virus in vivo mRNAs. Cell (1975) 2.15

Viral proteins required for the in vitro replication of vesicular stomatitis virus defective interfering particle genome RNA. Virology (1988) 2.11

Assembly of vesicular stomatitis virus glycoprotein and matrix protein into HeLa cell plasma membranes. J Mol Biol (1976) 2.10

Phosphorylation of vesicular stomatitis virus in vivo and in vitro. J Virol (1974) 2.07

Initiation and replication of vesicular stomatitis virus genome RNA in a cell-free system. Proc Natl Acad Sci U S A (1983) 1.95

Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91

In vitro replication of Sendai virus wild-type and defective interfering particle genome RNAs. J Virol (1985) 1.53

Vesicular stomatitis virus envelope glycoprotein alterations induced by host cell transformation. Cell (1974) 1.45

Deletion analysis defines a carboxyl-proximal region of Sendai virus P protein that binds to the polymerase L protein. Virology (1994) 1.44

The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology (1997) 1.41

Oligosaccharide moieties of the glycoprotein of vesicular stomatitis virus. J Virol (1976) 1.40

The Sendai virus V protein interacts with the NP protein to regulate viral genome RNA replication. Virology (1996) 1.40

Structure, transcription, and replication of measles virus. Curr Top Microbiol Immunol (1995) 1.35

Mutations in conserved domain I of the Sendai virus L polymerase protein uncouple transcription and replication. Virology (1995) 1.33

Domains of the measles virus N protein required for binding to P protein and self-assembly. Virology (1996) 1.32

Mutations in the measles virus C protein that up regulate viral RNA synthesis. Virology (2001) 1.27

In vivo methylation of vesicular stomatitis virus and its host-cell messenger RNA species. Virology (1976) 1.27

Host range mutants of vesicular stomatitis virus defective in in vitro RNA methylation. Proc Natl Acad Sci U S A (1982) 1.26

Encapsidation of Sendai virus genome RNAs by purified NP protein during in vitro replication. J Virol (1988) 1.24

The vesicular stomatitis virus L protein possesses the mRNA methyltransferase activities. Virology (1988) 1.23

Studies on the in vivo and in vitro messenger RNA species of vesicular stomatitis virus. Virology (1975) 1.23

A highly conserved region of the Sendai virus nucleocapsid protein contributes to the NP-NP binding domain. Virology (1997) 1.19

Alternative amino acids at a single site in the Sendai virus L protein produce multiple defects in RNA synthesis in vitro. Virology (1995) 1.13

Promoter analysis of the vesicular stomatitis virus RNA polymerase. Virology (1993) 1.10

Mutations in conserved domain II of the large (L) subunit of the Sendai virus RNA polymerase abolish RNA synthesis. Virology (1999) 1.07

Dissection of individual functions of the Sendai virus phosphoprotein in transcription. J Virol (1999) 1.05

Characterization of the infections of permissive and nonpermissive cells by host range mutants of vesicular stomatitis virus defective in RNA methylation. Virology (1984) 1.03

Synthesis of leader RNA and editing of the P mRNA during transcription by purified measles virus. J Virol (1991) 1.02

An amino-proximal domain of the L protein binds to the P protein in the measles virus RNA polymerase complex. Virology (1994) 1.02

Sendai virus wild-type and mutant C proteins show a direct correlation between L polymerase binding and inhibition of viral RNA synthesis. Virology (2001) 1.01

Mutations in conserved domains IV and VI of the large (L) subunit of the sendai virus RNA polymerase give a spectrum of defective RNA synthesis phenotypes. Virology (2000) 0.97

Comparison of identical temperature-sensitive mutations in the L polymerase proteins of sendai and parainfluenza3 viruses. Virology (2000) 0.97

Intracellular events in the replication of defective interfering particles of vesicular stomatitis virus. Virology (1979) 0.97

Mutations in domain V of the Sendai virus L polymerase protein uncouple transcription and replication and differentially affect replication in vitro and in vivo. Virology (2000) 0.97

Role of primary constitutive phosphorylation of Sendai virus P and V proteins in viral replication and pathogenesis. Virology (1999) 0.93

A simple method for the preparation of extracts from animal cells which catalyze efficient in vitro protein synthesis. J Biol Chem (1983) 0.93

Requirements for measles virus induction of RANTES chemokine in human astrocytoma-derived U373 cells. J Virol (1999) 0.92

Alteration of the 5' terminal caps of the mRNAs of vesicular stomatitis virus by cycloleucine in vivo. Virology (1981) 0.92

Identification of nucleocapsid protein residues required for Sendai virus nucleocapsid formation and genome replication. J Gen Virol (1999) 0.87

Double-stranded RNA adenosine deaminase activity during measles virus infection. Virus Res (1995) 0.87

Measles virus nucleocapsid protein can function in Sendai virus defective interfering particle genome synthesis in vitro. Virology (1995) 0.87

Hypermutation of the phosphoprotein and altered mRNA editing in the hamster neurotropic strain of measles virus. Virology (1995) 0.82

Characterization of the non-permissive infection of rabbit cornea cells by vesicular stomatitis virus. J Gen Virol (1980) 0.82

Characterization of paramyxoviruses isolated from three snakes. Virus Res (1996) 0.78

Determinants of serotype specificity in transcription of vesicular stomatitis virus synthetic nucleocapsids. Virology (1994) 0.77

The specific inhibition of vesicular stomatitis virus replication by toyocamycin. Virology (1979) 0.75